Hemostemix Inc.: Hemostemix Partners with My Next Health, Obtains USD $150,000 Subscription at CAD $0.25 Per Unit, and Incorporates Functional Genomics

Calgary, Alberta--(Newsfile Corp. - January 21, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it has signed a Global Master Services

Related Keywords

Canada ,Canadian ,Thomas Smeenk ,Richard Heinzl ,Regulation Service Provider ,World Economic Forum Technology Pioneer Award ,Hemostemix Inc ,My Next Health Inc ,My Next Health ,Alberta Newsfile Corp ,Global Master Services Agreement ,Venture Exchange ,Next Health ,Ischemic Cardiomyopathy ,Stem Cell Treatment ,Regulating Stem Cells ,Vitro Techniques ,Stem Cells ,Neural Lineage ,Automated Cell ,Looking Information ,Common Shares ,Hemostemix ,Partners ,Text ,Health ,Btains ,Subscription ,Unit ,Incorporates ,Unctional ,Genomics ,